Wed, Aug 27, 2014, 6:24 AM EDT - U.S. Markets open in 3 hrs 6 mins

Recent

% | $
Quotes you view appear here for quick access.

Skullcandy, Inc. (SKUL) Message Board

builtrite34 7 posts  |  Last Activity: Aug 21, 2014 7:16 PM Member since: Jan 29, 2003
SortNewest  |  Oldest  |  Highest Rated Expand all messages
  • Reply to

    Annual Meeting

    by gamman2758 Aug 21, 2014 2:20 PM
    builtrite34 builtrite34 Aug 21, 2014 7:16 PM Flag

    How about some sales? What happened to all the great expexcations?

  • Reply to

    Annual Meeting

    by gamman2758 Aug 21, 2014 2:20 PM
    builtrite34 builtrite34 Aug 21, 2014 3:46 PM Flag

    As of June 30, 2014, the Company had a working capital deficit of $7,225,921 and cash of $443,788, compared to a working capital deficit of $4,080,488 and cash of $236,597 as of December 31, 2013. In December 2011, the Company entered into an Engagement Agreement with Laidlaw & Company (UK) Ltd., which Engagement Agreement was amended in July 2012. Under the Engagement Agreement, Laidlaw agreed to assist the Company in raising up to $20.0 million in capital over a two year period from the date of the Engagement Agreement. Subsequent to June 30, 2013, the Company has engaged other agents to assist the Company with raising capital and has commenced raising capital on its own. During the six months ended June 30, 2014, The Company raised $1,376,376, net of transaction costs of $130,000, under these agreements. However, if the Company does not receive additional funds in a timely manner, the Company could be in jeopardy as a going concern. The Company may not be able to find alternative capital or raise capital or debt on terms that are acceptable. Management believes that if the events defined in the Engagement Agreements occur as expected, or if the Company is otherwise able to raise a similar level of funds, such proceeds will be sufficient to allow the Company to sustain operations until it attains profitability and positive cash flows from operations. However, the Company may incur unknown expenses or may not be able to meet its revenue expectations requiring it to seek additional capital. In such event, the Company may not be able to find capital or raise capital or debt on terms that are acceptable.

  • Reply to

    Annual Meeting

    by gamman2758 Aug 21, 2014 2:20 PM
    builtrite34 builtrite34 Aug 21, 2014 3:41 PM Flag

    Business

    SpectraScience, Inc. (the "Company," "SpectraScience," "we," "our," or "us") develops and manufactures innovative Laser Induced Fluorescence spectrophotometry systems capable of determining whether tissue is normal, pre-cancerous or cancerous without removing tissue from the body. The WavSTAT Optical Biopsy System (the "WavSTAT System") is SpectraScience's first product to incorporate its proprietary fluorescence technology for clinical use. The WavSTAT System carries the CE mark designation which allows for the sale and marketing in the European Union for the diagnosis of cancer. We are developing light-based diagnostics for additional indications including inflammatory bowel disease and esophageal cancer. Once these additional applications are developed we plan to self-certify for CE mark approval for sale in the European Union and then file an application with the FDA seeking permission to begin marketing for that indication for use in the United States. We believe we have a strong intellectual property portfolio that will allow us to continue to expand our WavSTAT cancer diagnosis platform to address the diagnosis of multiple cancers, utilize additional proprietary bio-photonic techniques to improve the WavSTAT's overall diagnostic performance and ultimately allow for the detection of cancer and pre-cancer over a relatively large area of examined tissue.

    Our principal executive offices are located at 11568 Sorrento Valley Rd., Suite 11, San Diego, CA 92121. We can be reached by telephone at (858) 847-0200; by fax at (858) 847-0880; or by email at info@spectrascience.com. We have a Web site at http://www.spectrascience.com. The information contained on our Web site shall not be deemed to be a part of this Report.

    Plan of Operation

    During the three and six month periods ended June 30, 2014, SpectraScience carried forward on the improvements made to the WavSTAT4 in fiscal 2011 and continued working with PENTAX Europe, GmbH ("PENTAX"), for distribution of its products in Europe, the Middle East and Africa.

    Over the next 12 months, SpectraScience intends to:

    Market and sell the WavSTAT4 Optical Biopsy System colon cancer diagnostic application through PENTAX in the European Union;

    Conduct country-specific evaluation trials to demonstrate the effectiveness and cost benefit of the WavSTAT4 Optical Biopsy System in each relevant European jurisdiction;

    Coordinate the creation and publication of scientific papers and presentations related to the country-specific evaluation trials to support widespread education and adoption of the WavSTAT4 ;

    Pursue the introduction of the WavSTAT4 colon cancer application in other international markets, in particular Saudi Arabia, Russia and India;

    Begin meeting with the FDA towards the preparation and submission of a Supplemental PMA filing with the FDA for the WavSTAT4 and plan for additional clinical trials to support eventual approval for sale in the United States;

    Begin the design and planning for the next generation of multi-modal fluorescence and broadband spectroscopy systems at our facility in San Diego, California; and

    Continue to expand and refine our intellectual property portfolio.

    Results of Operations

  • Reply to

    Annual Meeting

    by gamman2758 Aug 21, 2014 2:20 PM
    builtrite34 builtrite34 Aug 21, 2014 3:33 PM Flag

    I actually just bought some 20000 at .025 figured it was worth a 40 percent gain in the next week

  • builtrite34 builtrite34 Aug 21, 2014 3:22 PM Flag

    I take it no good news from the meeting today? Think they would have posted something if there were good news.

  • builtrite34 builtrite34 Aug 21, 2014 3:19 PM Flag

    more shares for sale more dilution of those who supported SCIE the whole time, icky and no sales aqain last quarter? Right

  • Reply to

    Annual Meeting

    by gamman2758 Aug 21, 2014 2:20 PM
    builtrite34 builtrite34 Aug 21, 2014 2:58 PM Flag

    If this machine really works, wouldn't there be buyers lined up out the door?

SKUL
8.21-0.02(-0.24%)Aug 26 4:00 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.